Potential clinical factors associated with secukinumab dose selection in the treatment of hidradenitis suppurativa: a cohort study of 132 patients
J Dermatolog Treat
.
2025 Dec;36(1):2512156.
doi: 10.1080/09546634.2025.2512156.
Epub 2025 Jun 4.
Authors
Alberto Soto Moreno
1
,
Sofía Haselgruber
1
2
,
Giovanna F Osorio-Gomez
3
,
Pablo Fernandez-Crehuet
4
,
Juan Ortiz-Alvarez
3
,
Juan M Segura-Palacios
5
,
Pedro Navarro-Guillamon
6
,
Alicia Padial Gomez-Torrente
7
,
Maria D Fernandez-Ballesteros
8
,
Jose M Llamas-Molina
9
,
Fiorella Vasquez-Chinchay
10
,
Claudia Guerrero-Ramirez
11
,
Marisol Contreras-Steyls
5
,
Marina Romero-Bravo
8
,
Alejandro Molina-Leyva
1
2
Affiliations
1
Dermatology, Hospital Universitario Virgen de las Nieves - Ibs. Granada, Granada, Spain.
2
European Hidratenitis Suppurativa Foundation, Dessau, Germany.
3
Dermatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
4
Hospital Universitario Reina Sofía, Córdoba, Spain.
5
Hospital Universitario Costa del Sol, Marbella, Spain.
6
Hospital Universitario Virgen de la Victoria, Málaga, Spain.
7
Hospital Universitario Jerez de la Frontera, Cádiz, Spain.
8
Hospital Regional Universitario de Málaga, Málaga, Spain.
9
Hospital Universitario San Cecilio, Granada, Spain.
10
Hospital Universitario Virgen de Valme, Sevilla, Spain.
11
Hospital Universitario Torrecárdenas, Almería, Spain.
PMID:
40574590
DOI:
10.1080/09546634.2025.2512156
No abstract available